Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Exelon Corporation (EXC), Duke Energy Corp (DUK), TECO Energy, Inc. (TE): 1 Big Change in This Dividend Stock’s Strategy

Page 1 of 2

Exelon Corporation (NYSE:EXC) presented at the Barclays CEO Energy Conference earlier this week, giving investors a sneak peek into this company’s future plans. With nuclear on the fritz and natural gas prices up and down, here’s the latest on Exelon’s adventures.

Competition’s overrated

Exelon Corporation (NYSE:EXC) may have 35,000 MW of competitive capacity to its name and 20% of our nation’s entire nuclear fleet, but it’s got more on its mind than competition . Power prices have fallen 44% since 2008 , and competitive economies just are not what they used to be. Despite the company’s 10,000 MW  natural gas “hedge” on its nuclear assets, the company announced additional $350 to $400 million reductions off 2014 and 2015 sales estimates as PJM prices stay dirt cheap .

Derisked regulation

To make up for risky and potentially problematic competitive sales, Exelon Corporation (NYSE:EXC) is focusing on its regulated subsidiaries. Currently, the company operates three major utilities serving 6.6 million customers across Illinois, Maryland, and Pennsylvania . In the next two years, Exelon will invest a whopping $13.5 billion of growth capital into its utilities, and will push regulators for a coinciding rate base growth of 5% to 6% annually.

While the majority of each utility’s rate base is allocated to electricity distribution, the company is also expanding its transmission and gas delivery services. For investors, the most important metric to keep an eye on is return-on-equity (ROE)-essentially the percentage amount that regulators allow Exelon Corporation (NYSE:EXC) to keep as profit. With 7% to 8% ROE at its BGE utility and 8% to 9% at ComEd, there’s plenty of room for improvement .

Source: Exelon

Other utilities have been ragging on regulators for similar upgrades. Duke Energy Corp (NYSE:DUK) settled with South Carolina regulators earlier this week on a 10.2% ROE, the equivalent of a 8.2% rate hike for customers over the next two years. TECO Energy, Inc. (NYSE:TE) bid farewell to single-digit ROE in Florida, where regulators gave the go-ahead to 10.25% ROE for TECO’s Tampa Electric utility. The approval was more than welcome, considering TECO Energy, Inc. (NYSE:TE)’s CEO had previously expected ROE of less than 9% for 2013 .

Policy pushing

While Exelon Corporation (NYSE:EXC) pours capital into utilities and pushes regulators for new rates, it’s also continuing to push for positive policy. Despite owning 44 wind farms capable of generating 1,300 MW of clean electricity , the utility has been an outspoken opponent of extending production tax credits for wind . A removal would’ve decimated wind-centric NextEra Energy, Inc. (NYSE:NEE)‘s future plans to push its 10,000 MW fleet even further, but would’ve allowed Exelon’s other energies (namely nuclear) a better chance at competitive pricing. Congress approved the extension in January, and wind power is expected to increase 34% over the next three years.

But while Exelon didn’t have much luck with opposition, its support of Illinois’ Energy Infrastructure and Modernization plan proved more positive. Exelon has been a leader in the push for smart grid technology, and this approval put it and fellow Illinois utility Ameren Corp (NYSE:AEE) in positions to spend significantly more on these initiatives. Exelon expects the legislation to add $25 million to this year’s revenue, with an additional $65 million in 2014.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!